IP Library › Granted Patent US 10,537,549
Granted Patent B2
US 10,537,549 · App. 16/099,590 · Granted Jan 21, 2020

Dihydroisoxazole compound for use in controlling sea lice

Inventor: Chouaib Tahtaoui (Rixheim, FR)
Assignee: Elanco Tiergesundheit AG
A61K31/381A01N43/80A23K20/137A23K50/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,537,549
App. No.
16/099,590
Granted
Jan 21, 2020
Kind
B2
Abstract

The present invention provides a dihydroisoxazole of formula: or a salt thereof, for use in the control of sea lice in fish.

Claims (8)

1. A compound of the formula:

or a salt thereof.

2. A method of controlling sea lice in fish comprising administering to the fish a veterinary effective amount of a compound of the formula:

or a salt thereof.

3. The method according to claim 2 wherein the fish are salmonids.

4. The method according to claim 2 , wherein the compound, or a salt thereof, is orally administered.

5. A medicated fish feed comprising a compound of the formula:

or a salt thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2025
From: ELANCO TIERGESUNDHEIT AG
To: INTERVET INC.
Reel/Frame 070456/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2024
From: TAHTAOUI, CHOUAIB
To: NOVARTIS TIERGESUNDHEIT AG (NOW ELANCO TEIRGESUNDHEIT AG)
Reel/Frame 067344/0592 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2018
From: NOVARTIS TIERGESUNDHEIT AG
To: ELI LILLY AND COMPANY
Reel/Frame 047440/0557 →
Cited By (3)
US 12,280,040 US 12,304,903 US 12,655,138